US Stock MarketDetailed Quotes

RPHM Reneo Pharmaceuticals

Watchlist

1.410
-0.030-2.08%

Trading Aug 5 11:42 ET

47.12MMarket Cap-649P/E (TTM)

Reneo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-132.25%-21.01M

-34.46%-63.68M

-26.52%-19.75M

-73.87%-18.77M

-34.78%-16.11M

-0.54%-9.05M

-24.69%-47.36M

-55.80%-15.61M

-11.60%-10.79M

-23.25%-11.96M

Net income from continuing operations

44.22%-8.43M

-48.95%-77.39M

-73.19%-23.55M

-47.58%-19.2M

-58.63%-19.53M

-15.89%-15.11M

-30.64%-51.96M

-28.22%-13.6M

-2.14%-13.01M

-33.59%-12.31M

Operating gains losses

433.33%16K

----

--2K

--0

--3K

----

Depreciation and amortization

-60.98%16K

93.18%170K

76.00%44K

95.45%43K

90.91%42K

115.79%41K

76.00%88K

47.06%25K

69.23%22K

120.00%22K

Other non cash items

-83.86%67K

1,180.77%333K

-1,707.58%-1.06M

183.33%306K

601.04%673K

270.08%415K

--26K

--66K

--108K

--96K

Change In working capital

-346.67%-12.86M

1,174.04%12.22M

251.84%4.08M

-84.72%189K

467.25%2.74M

65.28%5.21M

134.25%959K

-144.05%-2.69M

-35.03%1.24M

57.31%-745K

-Change in prepaid assets

32.38%2.58M

73.58%1.52M

-86.94%-501K

100.41%483K

62.93%-410K

-2.93%1.95M

118.64%878K

76.37%-268K

121.52%241K

27.62%-1.11M

-Change in payables and accrued expense

-552.12%-15.36M

2,046.33%11.12M

298.75%4.61M

-116.46%-183K

593.05%3.29M

171.62%3.4M

-70.90%518K

-6,344.44%-2.32M

-62.68%1.11M

300.42%475K

-Change in other current liabilities

41.61%-80K

2.97%-424K

69.70%-30K

4.31%-111K

-28.07%-146K

-26.85%-137K

-433.59%-437K

-243.48%-99K

-363.64%-116K

-670.00%-114K

Cash from discontinued investing activities

Operating cash flow

-132.25%-21.01M

-34.46%-63.68M

-26.52%-19.75M

-73.87%-18.77M

-34.78%-16.11M

-0.54%-9.05M

-24.69%-47.36M

-55.80%-15.61M

-11.60%-10.79M

-23.25%-11.96M

Investing cash flow

Cash flow from continuing investing activities

-25.67%13.76M

118.19%10.52M

247.77%39.78M

146.77%21.25M

-859.78%-69.01M

241.02%18.51M

-147.44%-57.84M

-430.15%-26.92M

-907.65%-45.44M

133.65%9.08M

Net PPE purchase and sale

--0

36.13%-221K

90.00%-25K

32.14%-19K

79.17%-5K

-290.91%-172K

-74.75%-346K

-177.78%-250K

63.64%-28K

-300.00%-24K

Net investment purchase and sale

-26.35%13.76M

118.68%10.74M

249.25%39.8M

146.84%21.27M

-857.72%-69.01M

241.42%18.68M

-148.06%-57.5M

-423.51%-26.67M

-924.53%-45.41M

133.74%9.11M

Cash from discontinued investing activities

Investing cash flow

-25.67%13.76M

118.19%10.52M

247.77%39.78M

146.77%21.25M

-859.78%-69.01M

241.02%18.51M

-147.44%-57.84M

-430.15%-26.92M

-907.65%-45.44M

133.65%9.08M

Financing cash flow

Cash flow from continuing financing activities

12,822.51%60.87M

-1,370.15%-4.13M

78.35%173K

148,297.67%63.81M

16,716.67%1.01M

-99.64%471K

173.11%325K

-56.31%97K

-99.95%43K

Net common stock issuance

--0

31,058.03%60.14M

-2,381.35%-4.4M

--0

1,058,916.67%63.53M

16,716.67%1.01M

-99.77%193K

765.52%193K

--0

---6K

Proceeds from stock option exercised by employees

----

162.59%730K

108.33%275K

78.35%173K

----

-50.00%278K

-11.41%132K

-55.91%97K

----

Cash from discontinued financing activities

Financing cash flow

--0

12,822.51%60.87M

-1,370.15%-4.13M

78.35%173K

148,297.67%63.81M

16,716.67%1.01M

-99.64%471K

173.11%325K

-56.31%97K

-99.95%43K

Net cash flow

Beginning cash position

38.67%27.63M

-84.01%19.93M

-81.11%11.74M

-92.32%9.08M

-74.90%30.4M

-84.01%19.93M

132.52%124.66M

-50.85%62.13M

-15.75%118.26M

32.75%121.09M

Current changes in cash

-169.33%-7.26M

107.36%7.71M

137.66%15.9M

104.73%2.66M

-653.14%-21.31M

393.55%10.47M

-247.41%-104.73M

-2,313.09%-42.21M

-302.12%-56.13M

-105.76%-2.83M

End cash Position

-32.97%20.38M

38.67%27.63M

-81.11%11.74M

-92.32%9.08M

-74.90%30.4M

-84.01%19.93M

-50.85%62.13M

-15.75%118.26M

Free cash flow

-127.92%-21.01M

-33.95%-63.9M

-24.68%-19.78M

-73.59%-18.79M

-34.55%-16.12M

-1.96%-9.22M

-24.95%-47.71M

-56.89%-15.86M

-11.01%-10.82M

-23.42%-11.98M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-132.25%-21.01M	-34.46%-63.68M	-26.52%-19.75M	-73.87%-18.77M	-34.78%-16.11M	-0.54%-9.05M	-24.69%-47.36M	-55.80%-15.61M	-11.60%-10.79M	-23.25%-11.96M
Net income from continuing operations	44.22%-8.43M	-48.95%-77.39M	-73.19%-23.55M	-47.58%-19.2M	-58.63%-19.53M	-15.89%-15.11M	-30.64%-51.96M	-28.22%-13.6M	-2.14%-13.01M	-33.59%-12.31M
Operating gains losses	433.33%16K	----	----	--2K	--0	--3K	----	----	----	----
Depreciation and amortization	-60.98%16K	93.18%170K	76.00%44K	95.45%43K	90.91%42K	115.79%41K	76.00%88K	47.06%25K	69.23%22K	120.00%22K
Other non cash items	-83.86%67K	1,180.77%333K	-1,707.58%-1.06M	183.33%306K	601.04%673K	270.08%415K	--26K	--66K	--108K	--96K
Change In working capital	-346.67%-12.86M	1,174.04%12.22M	251.84%4.08M	-84.72%189K	467.25%2.74M	65.28%5.21M	134.25%959K	-144.05%-2.69M	-35.03%1.24M	57.31%-745K
-Change in prepaid assets	32.38%2.58M	73.58%1.52M	-86.94%-501K	100.41%483K	62.93%-410K	-2.93%1.95M	118.64%878K	76.37%-268K	121.52%241K	27.62%-1.11M
-Change in payables and accrued expense	-552.12%-15.36M	2,046.33%11.12M	298.75%4.61M	-116.46%-183K	593.05%3.29M	171.62%3.4M	-70.90%518K	-6,344.44%-2.32M	-62.68%1.11M	300.42%475K
-Change in other current liabilities	41.61%-80K	2.97%-424K	69.70%-30K	4.31%-111K	-28.07%-146K	-26.85%-137K	-433.59%-437K	-243.48%-99K	-363.64%-116K	-670.00%-114K
Cash from discontinued investing activities
Operating cash flow	-132.25%-21.01M	-34.46%-63.68M	-26.52%-19.75M	-73.87%-18.77M	-34.78%-16.11M	-0.54%-9.05M	-24.69%-47.36M	-55.80%-15.61M	-11.60%-10.79M	-23.25%-11.96M
Investing cash flow
Cash flow from continuing investing activities	-25.67%13.76M	118.19%10.52M	247.77%39.78M	146.77%21.25M	-859.78%-69.01M	241.02%18.51M	-147.44%-57.84M	-430.15%-26.92M	-907.65%-45.44M	133.65%9.08M
Net PPE purchase and sale	--0	36.13%-221K	90.00%-25K	32.14%-19K	79.17%-5K	-290.91%-172K	-74.75%-346K	-177.78%-250K	63.64%-28K	-300.00%-24K
Net investment purchase and sale	-26.35%13.76M	118.68%10.74M	249.25%39.8M	146.84%21.27M	-857.72%-69.01M	241.42%18.68M	-148.06%-57.5M	-423.51%-26.67M	-924.53%-45.41M	133.74%9.11M
Cash from discontinued investing activities
Investing cash flow	-25.67%13.76M	118.19%10.52M	247.77%39.78M	146.77%21.25M	-859.78%-69.01M	241.02%18.51M	-147.44%-57.84M	-430.15%-26.92M	-907.65%-45.44M	133.65%9.08M
Financing cash flow
Cash flow from continuing financing activities	0	12,822.51%60.87M	-1,370.15%-4.13M	78.35%173K	148,297.67%63.81M	16,716.67%1.01M	-99.64%471K	173.11%325K	-56.31%97K	-99.95%43K
Net common stock issuance	--0	31,058.03%60.14M	-2,381.35%-4.4M	--0	1,058,916.67%63.53M	16,716.67%1.01M	-99.77%193K	765.52%193K	--0	---6K
Proceeds from stock option exercised by employees	----	162.59%730K	108.33%275K	78.35%173K	----	----	-50.00%278K	-11.41%132K	-55.91%97K	----
Cash from discontinued financing activities
Financing cash flow	--0	12,822.51%60.87M	-1,370.15%-4.13M	78.35%173K	148,297.67%63.81M	16,716.67%1.01M	-99.64%471K	173.11%325K	-56.31%97K	-99.95%43K
Net cash flow
Beginning cash position	38.67%27.63M	-84.01%19.93M	-81.11%11.74M	-92.32%9.08M	-74.90%30.4M	-84.01%19.93M	132.52%124.66M	-50.85%62.13M	-15.75%118.26M	32.75%121.09M
Current changes in cash	-169.33%-7.26M	107.36%7.71M	137.66%15.9M	104.73%2.66M	-653.14%-21.31M	393.55%10.47M	-247.41%-104.73M	-2,313.09%-42.21M	-302.12%-56.13M	-105.76%-2.83M
End cash Position	-32.97%20.38M	38.67%27.63M	38.67%27.63M	-81.11%11.74M	-92.32%9.08M	-74.90%30.4M	-84.01%19.93M	-84.01%19.93M	-50.85%62.13M	-15.75%118.26M
Free cash flow	-127.92%-21.01M	-33.95%-63.9M	-24.68%-19.78M	-73.59%-18.79M	-34.55%-16.12M	-1.96%-9.22M	-24.95%-47.71M	-56.89%-15.86M	-11.01%-10.82M	-23.42%-11.98M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall